Back of the Napkin Bios

Back of the Napkin Bios

Yes, Capricor Has A Defence
And Yes, It Is Better Than The Market Thinks
Jul 28 • Back of the Napkin Bios
Long PTSD: My Top Ideas for the Next 12 Months
(Biology × Political Dislocation) ÷ Time-to-Catalyst = IRR
Jul 27 • Back of the Napkin Bios
The Acquirer’s Drift: Tempus AI Is A Buy
The Sell-Off Is The Entry
Jul 20 • Back of the Napkin Bios
The Quiet Validation
What Roche’s Double Failure Actually Tells Us About Huntington’s Disease
Jul 17 • Back of the Napkin Bios
IONS: We're Back, Part 2
Don't Miss The Forest From The Trees
Jul 16 • Back of the Napkin Bios
FDA Finalizes Its Psychedelics Guidance
Boring is Beautiful
Jul 14 • Back of the Napkin Bios
Steady As She Goes
The First Act Is About To Begin
Jul 13 • Back of the Napkin Bios
RPID: We’re Back
Step Right Up
Jul 10 • Back of the Napkin Bios

June 2026

New Sheriff in Town
The FDA Is Reversing Prasad’s Mistakes — and RGNX & REPL Are the Trade
Jun 28 • Back of the Napkin Bios
Cheap Now, Magnet Later
The Two-Stage Case for QURE
Jun 22 • Back of the Napkin Bios
Live from Leesburg: AMT-260, Neurona, and Why Context Matters
Epilepsy Foundation Pipeline Conference, June 19, 2026
Jun 20 • Back of the Napkin Bios
uniQure is a Railroad
The 2012 Vintage
Jun 10 • Back of the Napkin Bios
© 2026 Back of the Napkin Bios · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture